Tuberculosis News and Research

Latest Tuberculosis News and Research

Key bacterial protein structures reveal one of the biochemical secrets behind multi-drug tolerance

The structures of key bacterial proteins have revealed one of the biochemical secrets that enables bacteria to outwit antibiotics.

27 Sep 2012

IRIN examines reaction to Global Fund's new funding approach

"The Global Fund to Fight AIDS, Tuberculosis and Malaria has released initial details on its new funding model, ... but as the fund works to finalize the model before next year, civil society is criticizing the process for being untransparent and rushed," IRIN reports in an article examining the draft model and reaction to it.

27 Sep 2012

Coca Cola, Global Fund announce expansion of project to deliver medicines in rural areas

The Coca-Cola Company and the Global Fund to Fight AIDS, Tuberculosis and Malaria have announced the expansion of a pilot project, called "Project Last Mile," that uses Coca Cola's "'expansive global distribution system and core business expertise' to help deliver critical medicines to remote parts of the world, beginning in rural Africa," Pharma Times reports.

27 Sep 2012

Presidential candidates should address HIV epidemic more directly

Following the XIX International AIDS Conference (AIDS 2012) in July, "delegates left Washington with a clear focus on achieving an AIDS-free generation," Chip Lyons, president and CEO of the Elizabeth Glaser Pediatric AIDS Foundation, writes in the Huffington Post's "The Big Push" blog.

26 Sep 2012

Forbes features interview with president of Friends of Global Fight

Forbes features an interview with Deborah Derrick, president of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria, in which she "discusse[s] her motivations for pursuing a career in international affairs and social change, her experience as a senior program officer at the [Bill & Melinda Gates Foundation], what lessons she learned during her time at Gates that are most applicable in her new executive role at Friends of the Global Fight, the current landscape of challenges and solutions, and the role of technology in accelerating progress."

26 Sep 2012

Sufficient resources needed to maintain progress against AIDS, TB, malaria

"This week, heads of state, celebrities and CEOs will attend U.N. Secretary General Ban Ki-moon's 'Every Woman, Every Child' dinner in New York," an event that "will highlight the amazing contribution of the Global Fund to Fight AIDS, Tuberculosis and Malaria to the health of women and children in developing countries," Lucy Chesire, executive director and secretary to the board of TB ACTION Group, writes in the Huffington Post's "The Big Push" blog.

26 Sep 2012

Chinese innovations, resources could help create new global health products

In this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Christine Rousseau, a program officer at the foundation, describes the importance of diagnostics in HIV/AIDS and tuberculosis (TB) care and treatment and writes, This brings me to the tremendous role that China's entrepreneurs can play as partners in global health.

26 Sep 2012

'Big Push' needed to ensure political will necessary to maintain progress against AIDS, TB, malaria

"What will the day be like when we finally defeat AIDS, tuberculosis and malaria?" Arianna Huffington, president and editor-in-chief of the Huffington Post Media Group, asks in the Huffington Post's "The Big Push" blog.

26 Sep 2012

IVAC at Johns Hopkins announces grant recipients of World Pneumonia Day Advocacy Program

The International Vaccine Access Center (IVAC) at the Johns Hopkins Bloomberg School of Public Health (JHSPH) announced today recipients of the 2012 Small Grants for World Pneumonia Day Advocacy Program.

25 Sep 2012

U.S. foreign aid critical to achieving health goals, improving lives, strengthening international relationships

"Day after day, American foreign aid is dramatically improving millions of lives and consequently, impressions of America," former New Jersey Governor Thomas Kean and Ray Chambers, chair of the MDG Health Alliance and the U.N. Secretary-General's Special Envoy for Malaria, write in the Huffington Post's "Global Motherhood" blog.

21 Sep 2012

Sanofi, TB Alliance form research collaboration to search for new treatment compounds

French drug maker Sanofi on Thursday announced a new three-year research collaboration agreement with the TB Alliance "to accelerate the discovery and development of novel compounds against tuberculosis," RTTNews reports.

21 Sep 2012

U.N. report on MDGs shows declining aid; SG Ban urges increased global partnership

U.N. Secretary-General Ban Ki-moon on Thursday "urged a stronger global partnership to advance progress on the development targets world leaders have pledged to achieve by 2015, as a new United Nations report finds that significant gains risk slowing due to declining aid," the U.N. News Centre reports.

21 Sep 2012

September issue of 'Global Fund News Flash' email newsletter available

The Global Fund to Fight AIDS, Tuberculosis and Malaria has published Issue 8 of its newsletter, the "Global Fund News Flash."

21 Sep 2012

MD Anderson introduces Moon Shots Program to reduce cancer deaths

The University of Texas MD Anderson Cancer Center announces the launch of the Moon Shots Program, an unprecedented effort to dramatically accelerate the pace of converting scientific discoveries into clinical advances that reduce cancer deaths.

21 Sep 2012

First phase of Global Fund-managed AMFm shows success in bringing malaria drugs to clinics

The Affordable Medicines Facility-malaria (AMFm) -- an innovative financing mechanism that subsidizes the cost of artemisinin-based combination therapies (ACTs) in order to expand access to the most effective treatment for malaria -- "brought more than 100 million doses of malaria drugs to clinics and pharmacies in 2011" and "also increased access to the top malaria medicines by 26 to 52 percent in six countries."

21 Sep 2012

TB Alliance, Sanofi partner to discover and develop novel compounds against tuberculosis

Sanofi and the Global Alliance for TB Drug Development announced today a new research collaboration agreement to accelerate the discovery and development of novel compounds against tuberculosis (TB), a deadly infectious disease that resulted in almost 1.5 million deaths worldwide in 2010.

21 Sep 2012

Global health funding cuts threatening fight against HIV, TB in Eastern Europe, Central Asia, NGO report says

The fight against HIV and tuberculosis (TB) in Eastern Europe and Central Asia is being threatened by cuts in global health funding, according to "a report [.pdf] by leading European non-governmental health organizations," Reuters reports.

20 Sep 2012

Improved health critical to development of democracy in Burma

In this post in the Huffington Post Blog, Deborah Derrick, president of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria, examines the role of health efforts in the rebuilding of Burma, also known as Myanmar.

19 Sep 2012

Pfizer announces that 14 abstracts for tofacitinib to be presented at ACR/ARHP annual meeting

Pfizer Inc. announced today that 14 abstracts for tofacitinib, an investigational oral Janus kinase (JAK) inhibitor for the treatment of adults with moderate-to-severe active rheumatoid arthritis (RA), will be presented at the American College of Rheumatology (ACR) / Association of Rheumatology Health Professionals (ARHP) 2012 Annual Meeting, which is being held November 9-14 in Washington, D.C.

18 Sep 2012

Global Fund Board adopts new approach to funding grants

According to a press release from the Global Fund to Fight AIDS, Tuberculosis and Malaria, the fund's Board on Friday "voted to adopt a new approach to funding grants that will enable the organization to invest the world's money more strategically and for greater impact."

17 Sep 2012

Tuberculosis News and Research

Latest Tuberculosis News and Research

Key bacterial protein structures reveal one of the biochemical secrets behind multi-drug tolerance

IRIN examines reaction to Global Fund's new funding approach

Coca Cola, Global Fund announce expansion of project to deliver medicines in rural areas

Presidential candidates should address HIV epidemic more directly

Forbes features interview with president of Friends of Global Fight

Sufficient resources needed to maintain progress against AIDS, TB, malaria

Chinese innovations, resources could help create new global health products

'Big Push' needed to ensure political will necessary to maintain progress against AIDS, TB, malaria

IVAC at Johns Hopkins announces grant recipients of World Pneumonia Day Advocacy Program

U.S. foreign aid critical to achieving health goals, improving lives, strengthening international relationships

Sanofi, TB Alliance form research collaboration to search for new treatment compounds

U.N. report on MDGs shows declining aid; SG Ban urges increased global partnership

September issue of 'Global Fund News Flash' email newsletter available

MD Anderson introduces Moon Shots Program to reduce cancer deaths

First phase of Global Fund-managed AMFm shows success in bringing malaria drugs to clinics

TB Alliance, Sanofi partner to discover and develop novel compounds against tuberculosis

Global health funding cuts threatening fight against HIV, TB in Eastern Europe, Central Asia, NGO report says

Improved health critical to development of democracy in Burma

Pfizer announces that 14 abstracts for tofacitinib to be presented at ACR/ARHP annual meeting

Global Fund Board adopts new approach to funding grants

Forensics and toxicology - Industry Focus eBook eBook

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Tuberculosis News and Research

Latest Tuberculosis News and Research

Forensics and toxicology - Industry Focus eBook eBook

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Newsletters you may be interested in